Search

Displaying results 6491 - 6500 of 8006 in total
  1. Drug

    Cannabichromene

    go.drugbank.com/drugs/DB14735
    Investigational

    A natural product found in Cannabis sativa and Helichrysum species.

    Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates
  2. Drug

    Tilorone

    go.drugbank.com/drugs/DB17965
    Experimental

    Categories: Antivirals for Systemic Use, Antiinfectives for Systemic Use
  3. Drug

    Ramosetron

    go.drugbank.com/drugs/DB09290
    Investigational

    Currently, ramosetron is only approved for use Japan and in certain Southeast Asian countries.

  4. Drug

    BMN-351

    go.drugbank.com/drugs/DB18186
    Investigational

    It is under investigation for the treatment of Duchenne Muscular Dystrophy (DMD).

  5. Drug

    Insulin efsitora alfa

    go.drugbank.com/drugs/DB19013
    Investigational

    alfa is under investigation in clinical trial NCT05662332 (A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for

  6. Drug

    EHC18

    go.drugbank.com/drugs/DB05114
    Experimental

    EHC18 is an immune regulation medicine. It is a broad spectrum of specific HCV proteins.

  7. Drug

    Nizofenone

    go.drugbank.com/drugs/DB13546
    Experimental

    Categories: Psychostimulants, Agents Used for ADHD and Nootropics, Compounds used in a research, industrial, or household setting
  8. Drug

    Fenpiprane

    go.drugbank.com/drugs/DB13439
    Experimental

    Categories: Drugs for Functional Gastrointestinal Disorders
  9. Drug

    Sovleplenib

    go.drugbank.com/drugs/DB17557
    Investigational

    Sovleplenib is a novel, investigational, selective small molecule inhibitor for oral administration targeting spleen tyrosine kinase (Syk).

  10. Drug

    Isoquinoline, 7-(2-(3,6-dihydro-4-(3-(trifluoromethyl)phenyl)-1(2h)-pyridinyl)ethyl)-

    go.drugbank.com/drugs/DB16204
    Investigational

    Isoquinoline, 7-(2-(3,6-dihydro-4-(3-(trifluoromethyl)phenyl)-1(2h)-pyridinyl)ethyl)- is under investigation in clinical trial NCT00545454 (Activity and Safety of Oral Administration of SSR150106XB for